Abbott Laboratories (ABT) insider buying

Healthcare · Medical Devices · Market cap $174.8B

13 open-market purchases of ABT by Abbott Laboratories's executives and directors since January 2026, worth $1M in total, from SEC Form 4 filings.

The most recent: Ro Khanna bought — on March 23, 2026.

The biggest buyer over the period is Daniel J Starks: 1 purchase, $1M.

By year

YearPurchasesValue
202613$1M

Biggest buyers

InsiderBuysValue
Daniel J Starks
1$1M
Ro Khanna
6$0
Richard Mccormick
2$0
Michael T. Mccaul
2$0
Thomas H. Kean, Jr.
2$0

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Mar 23, 2026 Ro Khanna
0$104.87— —
Mar 23, 2026 Ro Khanna
0$104.87— —
Mar 19, 2026 Richard Mccormick
0$107.16— —
Mar 19, 2026 Richard Mccormick
0$107.16— —
Mar 10, 2026 Ro Khanna
0$110.60— —
Mar 10, 2026 Ro Khanna
0$110.60— —
Feb 24, 2026 Ro Khanna
0$114.65— —
Feb 24, 2026 Ro Khanna
0$114.65— —
Feb 5, 2026 Michael T. Mccaul
0$109.03— —
Feb 5, 2026 Michael T. Mccaul
0$109.03— —
Feb 4, 2026 Daniel J Starks
10,000$108.73$1M Form 4
Jan 29, 2026 Thomas H. Kean, Jr.
0$106.03— —
Jan 29, 2026 Thomas H. Kean, Jr.
0$106.03— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ABT.
Open ABT in Investingly

Questions

Are Abbott Laboratories insiders buying the stock?

13 open-market purchases of ABT by Abbott Laboratories's executives and directors since January 2026, worth $1M in total, from SEC Form 4 filings. The most recent: Ro Khanna bought — on March 23, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Abbott Laboratories's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.